Zobrazeno 1 - 10
of 196
pro vyhledávání: '"Phillip G Febbo"'
Autor:
Michael S Leapman, Antonio C Westphalen, Niloufar Ameli, H Jeffrey Lawrence, Phillip G Febbo, Matthew R Cooperberg, Peter R Carroll
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0185535 (2017)
We aimed to directly compare results from multi-parametric prostate MRI (mpMRI) and a biopsy-based 17-gene RT-PCR assay providing a Genomic Prostate Score (GPS) among individuals who were candidates for active surveillance with low and intermediate r
Externí odkaz:
https://doaj.org/article/8a760b025e2d486fb847de4c34c0cd3e
Publikováno v:
PLoS Computational Biology, Vol 4, Iss 2, p e28 (2008)
Cancer is a heterogeneous disease often requiring a complexity of alterations to drive a normal cell to a malignancy and ultimately to a metastatic state. Certain genetic perturbations have been implicated for initiation and progression. However, to
Externí odkaz:
https://doaj.org/article/0bf4b488409945e58ec6c24335bba782
Autor:
Stephen J. Freedland, Salvatore V. Pizzo, Bercedis L. Peterson, Eric C. Westman, Wendy Demark-Wahnefried, Gayathri Devi, David Hwang, Pinchas Cohen, Phillip G. Febbo, Yunhua Zhao, Michael Pollak, Dmitriy Rokhfeld, Alok K. Tewari, W. Cooper Buschemeyer, John C. Mavropoulos
Supplementary Data from The Effects of Varying Dietary Carbohydrate and Fat Content on Survival in a Murine LNCaP Prostate Cancer Xenograft Model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89b9f14f945175e7636a8bd3383400ed
https://doi.org/10.1158/1940-6207.22527084
https://doi.org/10.1158/1940-6207.22527084
Autor:
Stephen J. Freedland, Salvatore V. Pizzo, Bercedis L. Peterson, Eric C. Westman, Wendy Demark-Wahnefried, Gayathri Devi, David Hwang, Pinchas Cohen, Phillip G. Febbo, Yunhua Zhao, Michael Pollak, Dmitriy Rokhfeld, Alok K. Tewari, W. Cooper Buschemeyer, John C. Mavropoulos
Purpose: Numerous dietary factors elevate serum levels of insulin and insulin-like growth factor I (IGF-I), both potent prostate cancer mitogens. We tested whether varying dietary carbohydrate and fat, without energy restriction relative to compariso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::352bf90c7655f3245ff103df74522f0c
https://doi.org/10.1158/1940-6207.c.6545325.v1
https://doi.org/10.1158/1940-6207.c.6545325.v1
Autor:
Howard L. McLeod, Mark J. Ratain, Michael J. Morris, M. Eileen Dolan, Susan G. Dorsey, Michiaki Kubo, Yusuke Nakamura, Michael J. Kelley, Michael A. Carducci, John F. Mahoney, Paula N. Friedman, Deanna L. Kroetz, Ivo Shterev, Phillip G. Febbo, Eric J. Small, Cynthia L. Renn, Flora Mulkey, Stefanie D. Krens, Dorothy Watson, Lois Weisman, Cameron Lassiter, Alexander B. Sibley, Heather E. Wheeler, Yoichi Furukawa, Susan Halabi, Jai Patel, William Kevin Kelly, Chen Jiang, Claudia Wing, Sherrie Lessans, Kouros Owzar, Daniel L. Hertz
1000 SNPs with greatest statistical association with cumulative docetaxel dose at grade 3+ neuropathy in CALGB 90401 discovery GWAS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e3a32f960da8ef5ef60d314598d5e4a
https://doi.org/10.1158/1078-0432.22468622
https://doi.org/10.1158/1078-0432.22468622
Autor:
Daniel J. George, Michael J. Morris, Eric J. Small, Himisha Beltran, Brian I. Rini, Phillip G. Febbo, Herbert I. Hurwitz, Bin Luo, Ivo Shterev, John C. Brady, Mark D. Starr, Yingmiao Liu, Susan Halabi, Andrew B. Nixon
Supplementary Data from Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca3cf6936da380693046daffdb61d86
https://doi.org/10.1158/1078-0432.22484208.v1
https://doi.org/10.1158/1078-0432.22484208.v1
Autor:
Michael A. Carducci, Angelo M. De Marzo, Robin Gurganus, Daniel J. George, Phillip G. Febbo, Helen Fedor, Antonio Jimeno, Alan W. Partin, Luciana Schultz, Roula Albadine, Ting Wang, S. Lindsay Davis, Kelly Mundy, Patricia A. Creel, David P. Wood, Susan Halabi, Michelle A. Rudek, George J. Netto, Andrew J. Armstrong
Purpose: Given discrepancies between preclinical and clinical observations of mammalian target of rapamycin (mTOR) inhibition in prostate cancer, we sought to determine the pharmacodynamic effects of the mTOR/TORC1 inhibitor rapamycin in men with int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d89e2c593bd06ba355c5eb1dd80c5a7
https://doi.org/10.1158/1078-0432.c.6519354
https://doi.org/10.1158/1078-0432.c.6519354
Autor:
Alain Ravaud, Robert J. Motzer, Michael Staehler, Olga Valota, Xun Lin, Rachel Li, Phillip G. Febbo, Audrey D. Goddard, Dejan Knezevic, Margarita Lopatin, Christer Svedman, Ahmed Magheli, Jean-Francois Martini, Bernard Escudier, Brian I. Rini
Distribution of RS results in T3 patients in the gene signature cohort. Abbreviations: RS, recurrence score; T3, stage III tumor.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3047e3d76bf561fc26cdca2d4f965e14
https://doi.org/10.1158/1078-0432.22470153.v1
https://doi.org/10.1158/1078-0432.22470153.v1
Autor:
Alain Ravaud, Robert J. Motzer, Michael Staehler, Olga Valota, Xun Lin, Rachel Li, Phillip G. Febbo, Audrey D. Goddard, Dejan Knezevic, Margarita Lopatin, Christer Svedman, Ahmed Magheli, Jean-Francois Martini, Bernard Escudier, Brian I. Rini
Purpose: Adjuvant sunitinib prolonged disease-free survival (DFS; HR, 0.76) in patients with locoregional high-risk renal cell carcinoma (RCC) in the S-TRAC trial (ClinicalTrials.gov NCT00375674). The 16-gene Recurrence Score (RS) assay was previousl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5decd5cf3fd0ebc7b81f4433c5843aec
https://doi.org/10.1158/1078-0432.c.6527442.v1
https://doi.org/10.1158/1078-0432.c.6527442.v1
Autor:
Howard L. McLeod, Mark J. Ratain, Michael J. Morris, M. Eileen Dolan, Susan G. Dorsey, Michiaki Kubo, Yusuke Nakamura, Michael J. Kelley, Michael A. Carducci, John F. Mahoney, Paula N. Friedman, Deanna L. Kroetz, Ivo Shterev, Phillip G. Febbo, Eric J. Small, Cynthia L. Renn, Flora Mulkey, Stefanie D. Krens, Dorothy Watson, Lois Weisman, Cameron Lassiter, Alexander B. Sibley, Heather E. Wheeler, Yoichi Furukawa, Susan Halabi, Jai Patel, William Kevin Kelly, Chen Jiang, Claudia Wing, Sherrie Lessans, Kouros Owzar, Daniel L. Hertz
Peripheral neuronal cells (Peri.4U) treated with docetaxel were found to have a significant decrease in sensitivity for A) mean process lengths but not for B) mean outgrowth intensity or C) relative straightness as measured after 24 hours post-drug t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01213f721229f9327ba93b99118e0ff2
https://doi.org/10.1158/1078-0432.22468634.v1
https://doi.org/10.1158/1078-0432.22468634.v1